Text Size
466 studies found for:    Open Studies | "Infant, Newborn, Diseases"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Recruiting Early Intervention in Cystic Fibrosis Exacerbation
Condition: Cystic Fibrosis
Intervention: Device: Home lung function and symptom monitoring
22 Recruiting High Frequency Oscillatory Ventilation for Acute Respiratory Distress Syndrome (ARDS)
Condition: Acute Respiratory Distress Syndrome
Interventions: Device: Lung protective CMV;   Device: HFO-RMs
23 Unknown † Pharmacokinetics of Linezolid in Children With Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Drug: Linezolid
24 Unknown † Control of Steatorrhea in Patients With Cystic Fibrosis and Pancreatic Insufficiency
Conditions: Exocrine Pancreatic Insufficiency;   Cystic Fibrosis
Intervention: Drug: Pancreatin
25 Recruiting Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome
Condition: Acute Respiratory Distress Syndrome (ARDS)
Interventions: Device: ECMO (Quadrox®, Jostra®, Maquet®);   Other: conventional care
26 Unknown † NPD Measurement in Infants
Condition: Cystic Fibrosis
Intervention:
27 Unknown † Airway Pressure Release Ventilation in Acute Lung Injury
Conditions: Acute Lung Injury;   Acute Respiratory Distress Syndrome;   Mechanical Ventilation
Interventions: Device: APRV;   Device: Conventional MV
28 Recruiting Use of G-CSF to Obtain Blood Cell Precursors
Conditions: Chronic Granulomatous Disease;   Healthy;   Immunologic Disease;   Leukocyte Adhesion Deficiency Syndrome;   Severe Combined Immunodeficiency
Intervention:
29 Recruiting Assessment of Lung Structure and Function of Infants Born Prematurely
Conditions: Premature Birth;   Bronchopulmonary Dysplasia;   Asthma
Intervention:
30 Unknown † Comparison Between RTX (Biphasic Cuirass Ventilator) and Physiotherapy in Cystic Fibrosis Patients
Condition: Cystic Fibrosis
Intervention: Procedure: physiotherapy
31 Not yet recruiting Cystic Fibrosis (CF) Exacerbation and Insulin Treatment
Conditions: Cystic Fibrosis;   Impaired Glucose Tolerance;   Pulmonary Exacerbation
Interventions: Drug: novorapid / humalog short acting insulin;   Drug: Novo Rapid Insulin (Novonordisk)
32 Unknown † Prospective Intervention Study on Vitamin D in Patients With Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Dietary Supplement: Supplementation with vitamin D2/D3
33 Not yet recruiting Reproductibility of TM-mode Ultrasound Diaphragm Measures in Patients With Acute Respiratory Distress in the ER
Condition: Respiratory Distress Syndrome, Adult
Interventions: Procedure: Diaphragm excursion measures 1;   Procedure: Diaphragm excursion measures 2
34 Unknown † Surfactant Lavage vs. Bolus Surfactant in Neonates With Meconium Aspiration
Condition: Meconium Aspiration Syndrome
Interventions: Drug: Bovine Lipid Extract Surfactant (administered by lavage);   Drug: Bovine Lipid Extract Surfactant (administered by bolus)
35 Unknown † Measurement of Carboxyhemoglobin by Gas Chromatography as an Index of Hemolysis
Conditions: ABO Incompatibility;   Hemolytic Disease of Newborn;   Neonatal Jaundice;   Neonatal Hyperbilirubinemia
Intervention:
36 Recruiting Prediction by Ultrasound of the Risk of Hepatic Cirrhosis in Cystic Fibrosis
Conditions: Cystic Fibrosis;   Pancreatic Insufficiency
Interventions: Procedure: Abdominal Ultrasound;   Other: Sample collection procedures
37 Recruiting Follow-up of Children With Gastrointestinal Malformations and Postnatal Surgery
Condition: Digestive System Abnormalities
Intervention:
38 Unknown † Determination of the Predictive Factors in the Reversibility or the Aggravation in the Disorders of the Glucose Metabolism in Cystic Fibrosis Patients
Condition: Diabetes in Cystic Fibrosis Patients
Intervention: Other: Prospective cohort with an annual follow-up
39 Recruiting Strategies to Optimize Positive End-expiratory Pressure (PEEP) in Patients With Acute Lung Injury
Conditions: Acute Lung Injury;   Acute Respiratory Distress Syndrome;   Respiratory Failure
Intervention: Procedure: PEEP titration
40 Recruiting Inhaled Extra-fine Hydrofluoalkane-beclomethasone (QVAR) in Premature Infants With Bronchopulmonary Dysplasia (BPD)
Condition: Bronchopulmonary Dysplasia
Intervention: Drug: Inhaled extra-fine hydrofluoalkane-beclomethasone (QVAR)
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
† Indicates status has not been verified in more than two years